Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trond Velde Bogsrud

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancerLars Tore Gyland Mikalsen, Marius Røthe Arnesen, Trond Velde Bogsrud, et al.
Medicine|September 10, 2024
Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy studyLivia Maria Frota Lima, Trond Velde Bogsrud, Hossein Gharib, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2025
Substantial decrease in tumor dose over subsequent cyles of [<sup>177</sup>Lu]Lu-PSMA-radioligand treatmentTrond Velde Bogsrud, Jolanta M Durski, Ola Engelsen, et al.
EJNMMI Research|June 26, 2016
Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinomaJacob Horsager, Kirstine Bak-Fredslund, Lars Peter Larsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2019
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV statusJon Magne Moan, Cecilie Delphin Amdal, Eirik Malinen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 21, 2024
¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerRune Sundset, Hege Sagstuen Haugnes, Alexander Perez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Oncologic 18F-FDG PET/CT: referring physicians' point of viewDimitrios Karantanis, Dimitrios Kalkanis, Martin Allen-Auerbach, et al.
Clinical Nuclear Medicine|July 1, 2025
I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CTCem Bilgin, Gokce Belge Bilgin, Bilge Dundar, et al.
European Journal of Radiology|June 6, 2015
Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastasesAnselm Schulz, Johannes Clemens Godt, Johann Baptist Dormagen, et al.
BMC Cancer|November 2, 2022
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphomaTrine Husby, Håkon Johansen, Trond Velde Bogsrud, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancerLars Tore Gyland Mikalsen, Marius Røthe Arnesen, Trond Velde Bogsrud, et al.
Medicine|September 10, 2024
Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy studyLivia Maria Frota Lima, Trond Velde Bogsrud, Hossein Gharib, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2025
Substantial decrease in tumor dose over subsequent cyles of [<sup>177</sup>Lu]Lu-PSMA-radioligand treatmentTrond Velde Bogsrud, Jolanta M Durski, Ola Engelsen, et al.
EJNMMI Research|June 26, 2016
Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinomaJacob Horsager, Kirstine Bak-Fredslund, Lars Peter Larsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2019
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV statusJon Magne Moan, Cecilie Delphin Amdal, Eirik Malinen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 21, 2024
¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerRune Sundset, Hege Sagstuen Haugnes, Alexander Perez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Oncologic 18F-FDG PET/CT: referring physicians' point of viewDimitrios Karantanis, Dimitrios Kalkanis, Martin Allen-Auerbach, et al.
Clinical Nuclear Medicine|July 1, 2025
I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CTCem Bilgin, Gokce Belge Bilgin, Bilge Dundar, et al.
European Journal of Radiology|June 6, 2015
Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastasesAnselm Schulz, Johannes Clemens Godt, Johann Baptist Dormagen, et al.
BMC Cancer|November 2, 2022
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphomaTrine Husby, Håkon Johansen, Trond Velde Bogsrud, et al.
Pageof 4